StockSelector.com
  Research, Select, & Monitor Tuesday, October 16, 2018 2:10:34 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Aclaris Therapeutics, Inc.$13.01($.40)(2.98%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Aclaris Therapeutics, Inc. has an overall rank of 6790 out of 7408 stocks based on 6 positive rankings and 9 negative rankings.

Positive Rankings
Estimated Revenue Growth
Aclaris Therapeutics rank is 24
Debt-to-Equity
Aclaris Therapeutics rank is 133
Low/Rising MACD
The MACD remains negative, but is rising... suggesting a possible near-term correction. Of companies with a negative, but rising MACD, Aclaris Therapeutics is ranked 293.
PEGValue
Aclaris Therapeutics has a PEG Value of $15.44. A stock is commonly considered to be fairly valued when its PE ratio equals its earnings growth rate. The PEG Value is the price where the PE Ratio, based on next year's earnings estimate, divided by the estimated growth rate over the next couple of years equals 1. This implies that if the company maintains its estimated growth rate, that the stock should gain 15.15% in the next year. Among companies with a PEG Value above the current stock price, Aclaris Therapeutics is ranked 682.
Oversold Stochastics
Aclaris Therapeutics rank is 1997
Price-to-Book
Aclaris Therapeutics rank is 2310
Negative Rankings
Negative Net Margin
Aclaris Therapeutics rank is 139
Price-to-Sales
Aclaris Therapeutics rank is 148
Down EPS Surprise
Aclaris Therapeutics missed the consensus earnings estimate when it last reported quarterly earnings.
90 Day Loss
Aclaris Therapeutics rank is 761
Negative ROA
Aclaris Therapeutics rank is 805
Negative ROE
Aclaris Therapeutics rank is 821
High Put/Call
Aclaris Therapeutics has a high Put/Call ratio of 0.96 on all open interest of options expiring in the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Aclaris Therapeutics is ranked 939.
10 Day Loss
Aclaris Therapeutics rank is 1132
High vPut/Call
Aclaris Therapeutics has a high Put/Call ratio of 0.47 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Aclaris Therapeutics is ranked 2385.







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.